Form 4: Director Rivas Buys COO Stock, Transfers Shares to Trust

The Cooper Companies director Maria Rivas purchased 1,000 shares of common stock and transferred 2,721 shares to a trust, as disclosed in a recent Form 4 filing.

Summary

• Maria Rivas, a director of The Cooper Companies, Inc. (COO), acquired 1,000 shares of common stock on December 18, 2025.
• The purchase was made at a price of $82.13 per share.
• Following this transaction, Maria Rivas beneficially owns 11,141 shares indirectly through The Maria Rivas Trust Dated June 24, 2013, for which she is the sole trustee.
• An additional 2,721 shares were transferred from her direct holdings to The Maria Rivas Trust Dated June 24, 2013.
• The transaction was made pursuant to a Rule 10b5-1(c) plan.
• A Power of Attorney, executed on November 4, 2025, authorizes specific individuals to file Section 16 reports on behalf of Maria Rivas.

Sentiment

Score: 7

Explanation: The director's purchase of company stock, even if pre-planned, generally indicates a positive outlook on the company's value and future prospects. The transfer to a trust is a personal estate planning matter and doesn't directly reflect company sentiment.

Positives

• A director, Maria Rivas, purchased 1,000 shares of company stock, indicating confidence in the company's future.
• The transaction was executed under a Rule 10b5-1(c) plan, suggesting a pre-planned investment strategy.

Future Outlook

The filing does not provide specific forward-looking statements or guidance regarding the company's future performance, focusing instead on an insider's transaction.

Management Comments

• The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 16 of the Securities Exchange Act of 1934.

Industry Context

This filing is an insider transaction report and does not provide information directly related to broader industry trends or competitive landscape. However, insider purchases can sometimes be seen as a positive signal within the healthcare products industry, indicating management's belief in the company's prospects.

Comparison to Industry Standards

• This filing is an insider transaction report and does not contain information suitable for comparison to industry-specific operational or financial benchmarks. It details a director's personal stock activity.

Corporate Governance

Related Party Transactions

• The transfer of 2,721 shares from Maria Rivas's direct holdings to The Maria Rivas Trust Dated June 24, 2013, where Maria Rivas is the sole trustee, constitutes a related party transaction in the context of beneficial ownership reporting.

Stakeholder Impact

• Shareholders: The director's purchase could be interpreted as a positive signal regarding the company's future performance and valuation.

Next Steps

• Maria Rivas will continue to file Forms 3, 4, and 5 as required by Section 16(a) of the Securities Exchange Act of 1934 for her holdings and transactions in Cooper Companies securities.

Key Dates

Recommendation

A director's purchase of company stock, particularly under a Rule 10b5-1 plan, generally signals confidence in the company's long-term prospects. However, this single transaction, while positive, does not provide sufficient fundamental or strategic information to change a broader investment thesis. It primarily serves as an affirmation of management's belief in the company's value, supporting a 'hold' position for current investors and suggesting further due diligence for new investors.

Keywords

Cooper Companies, COO, Maria Rivas, Insider Trading, Form 4, Stock Purchase, Director, Beneficial Ownership, 10b5-1 Plan